Skip to main content
Clinical Trials/CTRI/2016/08/007218
CTRI/2016/08/007218
Recruiting
未知

Clinical and dermoscopic evaluation of therapeutic response to intralesional platelet rich plasma versus triamcinolone acetonide in alopecia areata.

AKSHMI KANTH MALLADI0 sites40 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: null- alopecia areata
Sponsor
AKSHMI KANTH MALLADI
Enrollment
40
Status
Recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
AKSHMI KANTH MALLADI

Eligibility Criteria

Inclusion Criteria

  • Patients willing for the study.
  • All the patients presenting with circumscribed patch of hair loss without any signs of inflammation or scarring.
  • Patients who have not taken any treatment for alopecia areata during the last 3 months.
  • Patients age more than 18 years

Exclusion Criteria

  • Patients who are not willing for the study.
  • Patients with platelet count \< 1 lakh/mm3, hemoglobin \<10\.5 mg/mm3, serum albumin \<2\.5mg/mm3\.
  • Patients with pregnancy or lactation.
  • Extensive lesions (more than 5 lesions) or with secondary infection.

Outcomes

Primary Outcomes

Not specified

Similar Trials